AI assistant
Lifecare ASA — Director's Dealing 2026
Mar 13, 2026
3654_dirs_2026-03-13_ac276d32-28ff-46a5-81f4-6c3b58c622d4.pdf
Director's Dealing
Open in viewerOpens in your device viewer
LIFECARE
PRESS RELEASE
13 March 2026 16:49:00 CET
LIFECARE ASA: MANDATORY NOTIFICATION OF TRADE
The Company has been informed that Teigland Eiendom AS, a company closely associated with Trine Teigland, board member and primary insider of Lifecare ASA, has exercised 3,072,447 warrants in Warrants Series 1 for the subscription of 3,072,447 new shares in the Company at a price of NOK 0.3342 per share.
The Company has also been informed that Teigland Eiendom AS has sold 3,000,000 shares at a price of NOK 0.4824 per share.
Following this transaction, Teigland Eiendom AS holds 9,682,136 shares, no warrants in Warrant Series 1 and 7,860,000 warrants in Warrant Series 2 in the Company.
About us
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, [email protected], +47 40 05 90 40
Renete Kaarvik, CFO, [email protected], +47 94 83 82 42
This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-13 16:49 CET.
Attachments
260313 PDMR Attachment Teigland Eiendom Warrants
260313 PDMR Attachment Teigland Eiendom Shares
Lifecare ASA • Ytrebygdsvegen 215 • N-5258 Blomsterdalen